Conserved hepatic RNA signatures across multiple cohorts reveal novel mechanistic clues for advanced fibrosis in human MASLD.
Jessica L Maiers, Tiebing Liang, Tingbo Guo et al.
✦ AI-curated · Sources linked
In 30 seconds
This meta-analysis examined hepatic transcriptomic data from approximately 1000 patients with metabolic dysfunction-associated steatotic liver disease (MASLD) to identify mechanisms of fibrosis progression. The study found 846 differentially regulated genes linked to advanced fibrosis, highlighting pathways related to matrix organization, inflammation, and metabolism. Notably, increased immune and mesenchymal cell types were observed in advanced fibrosis cases.
Key findings
- Identified 846 differentially regulated genes associated with fibrosis progression (F3-4 vs. F0-1).
- Pathway analysis revealed involvement in matrix organization, inflammation, solute transport, and metabolism.
- Increased proportions of immune and mesenchymal cell types were noted in patients with advanced fibrosis.
- Putative ligand-receptor interactions linked to fibrosis were conserved across multiple datasets.
Why it matters
Understanding the conserved mechanisms of fibrosis in MASLD can aid in identifying potential therapeutic targets. This knowledge is crucial for developing effective anti-fibrotic treatments and improving patient outcomes.